WEBCAST: Learn How to Reuse Patient Trial Data to Mitigate Go/No-Go Product Development Decision Risks

In our complimentary webinar, “Learn How to Reuse Patient Trial Data to Mitigate Go/No-Go Product Development Decision Risks,” hear from former Merck KGaA SVP of Oncology, Reinhard von Roemeling, MD and discover the value behind Medidata’s Synthetic Control Data and 2017 Scrip Award winner Synthetic Control Arms -- first-of-their kind innovations that leverage our MEDS (Medidata Enterprise Data Store) clinical data repository -- built on decades of experience that help power more than 14,000 clinical trials. 

Synthetic Control Arms ultimately form a control arm that enable greater safety, efficacy and subgroup analyses in single arm trials, reduces the cost, time and overall burden of the entire clinical trial ecosystem, and results in higher trial success rates in subsequent trials.